GLAXO:NSE
GlaxoSmithKline Pharmaceuticals Ltd
₹ २,७४०.००
arrow_upward
+०.९८%(+२६.६०) 1D
नोभेम्बर २०, १५:३०:०३ GMT+५:३० · INR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for GLAXO...
Open
₹ २,७०१.००
High
₹ २,७४८.००
Low
₹ २,६८०.००
Mkt. cap
४.६४ खरब
Avg. vol.
९४.३२ हजार
Volume
८४.४८ हजार
Dividend
२.०८%
Quarterly dividend
₹ १४.२५
Ex-dividend date
२०२६ मे २९
P/E ratio
४०.४८
52-wk high
₹ ३,१२०.७०
52-wk low
₹ २,०८८.१०
EPS
₹ ६७.६८
Shares outstanding
१६.९४ करोड
No. of employees
३ हजार
Open
₹ २,७०१.००
High
₹ २,७४८.००
Low
₹ २,६८०.००
Mkt. cap
४.६४ खरब
Avg. vol.
९४.३२ हजार
Volume
८४.४८ हजार
Dividend
२.०८%
Quarterly dividend
₹ १४.२५
Ex-dividend date
२०२६ मे २९
P/E ratio
४०.४८
52-wk high
₹ ३,१२०.७०
52-wk low
₹ २,०८८.१०
EPS
₹ ६७.६८
Shares outstanding
१६.९४ करोड
No. of employees
३ हजार
News stories
From web sources and news partners
ChartMill
·
१ घण्टा पहिले
S&P 500 Unusual Volume Movers: AES, IBM, ROST, INTU
Barron's
·
३९ मिनेट पहिले
S&P 500’s Tech Sector Crosses Bear Market Threshold
New York Post
·
२७ मिनेट पहिले
S&P 500 and Dow enter correction territory, Nasdaq loses 2026 gains as Anthropic dives
Profile
GlaxoSmithKline Pharmaceuticals Ltd is an Indian research-based pharmaceutical and healthcare company, and a subsidiary of GSK. The company's product portfolio includes prescription medicines and vaccines. Its prescription medicines range across therapeutic areas such as anti-infectives, dermatology, gynaecology, diabetes, oncology, cardiovascular disease, and respiratory diseases. It also offers a range of vaccines, for the prevention of hepatitis A, hepatitis B, invasive disease caused by H, influenzae, chickenpox, diphtheria, pertussis, tetanus, rotavirus, cervical cancer, and others. Wikipedia
About GlaxoSmithKline Pharmaceuticals Ltd
CEO-
Employees३.१ हजार
Founded१९२४ नोभेम्बर १३
Headquarters-
SectorHealth Care
Industry-
Websiteindia-pharma.gsk.com